Clinical Trial Update: Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and tolerability of vildagliptin versus placebo in patients with type 2 diabetes and moderate to severe renal insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED